Combination Therapy Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Associated with Hepatic Failure

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|7|5|391-393

ISSN： 1574-8863

Source： Current Drug Safety, Vol.7, Iss.5, 2012-11, pp. : 391-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of tenofovir disoproxil fumarate therapy in Chinese chronic hepatitis B patients after multiple antiviral failures

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E43-E52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term entecavir or tenofovir disoproxil fumarate therapy in treatment‐naïve chronic hepatitis B patients in the real‐world setting

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 5, 2015-05 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

By Calza Leonardo   Trapani Filippo   Salvadori Caterina   Magistrelli Eleonora   Manfredi Roberto   Colangeli Vincenzo   Di Bari Maria Assunta   Borderi Marco   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 147-154

Informa Healthcare

Access to resources Recommend Favorite

Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation

By Yoshino Munehiro  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 2, 2012-04 ,pp. : 169-174

Springer Publishing Company

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug‐resistant strains of hepatitis B virus

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2265-2274

John Wiley & Sons Inc

Access to resources Recommend Favorite